Single dose pharmacokinetic study of flumequine after intravenous, intraperitoneal and oral administration to Atlantic halibut ( Hippoglossus hippoglossus) held in seawater at 9 °C
The pharmacokinetic properties of the antibacterial agent flumequine were studied after intravenous, intraperitoneal and oral administration to Atlantic halibut ( Hippoglossus hippoglossus) held in seawater at 9 °C and weighing 1.5-2.5 kg. Following intravenous injection the plasma drug concentratio...
Saved in:
Published in | Aquaculture Vol. 158; no. 3; pp. 215 - 227 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
15.12.1997
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The pharmacokinetic properties of the antibacterial agent flumequine were studied after intravenous, intraperitoneal and oral administration to Atlantic halibut (
Hippoglossus hippoglossus) held in seawater at 9 °C and weighing 1.5-2.5 kg. Following intravenous injection the plasma drug concentration-time profile showed three distinct phases. The distribution half life (
t
1
2
α) was estimated to be 0.8 h and the terminal elimination half life (
t
1
2
γ) to be 43 h. Total body clearance (Cl
T) was determined to be 0.052 1/kg h
−1. The volume of distribution at steady state,
V
d(
ss)
, was estimated to be 2.3 1/kg indicating good tissue penetration of flumequine in Atlantic halibut. The peak plasma concentration (
C
max) and the time to peak plasma concentrations (
T
max) were estimated to be 2.7 and 6.1 μg/ml and 20 and 10 h, respectively, following oral administration of medicated feed or intraperitoneal injection. The bioavailabilities were calculated to be 31 and 69%, respectively, following oral or intraperitoneal administration. Only traces (< 10 ng/ml) of the metabolite 7-hydroxy-flumequine were found in a few of the plasma samples. Based on a minimum inhibitory concentration (MIC) of 0.0625 μg/ml for susceptible strains, a single intraperitoneal injection of 25 mg/kg of flumequine maintain plasma levels in excess of 0.25 μg/ml corresponding to 4 times the MIC-value, for approximately 10 d. The corresponding value for a single oral dose of 25 mg/kg of flumequine given as medicated feed, was 5 d. |
---|---|
ISSN: | 0044-8486 1873-5622 |
DOI: | 10.1016/S0044-8486(97)00190-7 |